Search

Your search keyword '"Pierre Gallian"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Pierre Gallian" Remove constraint Author: "Pierre Gallian" Language english Remove constraint Language: english
64 results on '"Pierre Gallian"'

Search Results

1. Exploring cell-free assays for COVID-19 serosurvey

2. Orthopoxvirus Seroprevalence and Infection Susceptibility in France, Bolivia, Laos, and Mali

3. SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021

4. Arboviral Risk Associated with Solid Organ and Hematopoietic Stem Cell Grafts: The Prophylactic Answers Proposed by the French High Council of Public Health in a National Context

5. Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort studyResearch in context

6. Risk for Hepatitis E Virus Transmission by Solvent/Detergent–Treated Plasma

7. The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors

8. Zika Virus Circulation in Mali

9. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

10. Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France

11. Low seroprevalence of Zika virus in Cameroonian blood donors

12. Zika virus epidemiology in Bolivia: A seroprevalence study in volunteer blood donors.

13. Hepatitis E Virus Infections in Blood Donors, France

14. Epidemiology of Chikungunya Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational Study in Volunteer Blood Donors.

15. Seroprevalence Study of Anti-HEV IgG among Different Adult Populations in Corsica, France, 2019

16. Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

17. Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.

18. Emergence of Toscana Virus in Europe

19. Seroprevalence of Toscana Virus in Blood Donors, France, 2007

20. Hepatitis E Virus Infection in Sheltered Homeless Persons, France

21. Parvovirus 4 in Blood Donors, France

22. Human Parvovirus 4 in Kidney Transplant Patients, France

23. Transfusion-associated Hepatitis E, France

24. Low neutralization capacity against SARS‐CoV ‐2 Omicron BQ .1.1 of convalescent plasma collected during circulation of Omicron BA .1

25. Seroprevalence surveys in blood donors population and complexity of immunization patterns

26. Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021

27. Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19

28. Zika Virus Circulation in Mali

29. SARS-CoV-2 and post-donation information: a one-year experience of the French haemovigilance network

30. Reduced neutralizing antibody potency of COVID ‐19 convalescent vaccinated plasma against SARS‐CoV ‐2 Omicron variant

31. COVID‐19 convalescent plasma: Evolving strategies for serological screening in France

32. Cluster of COVID-19 in northern France: A retrospective closed cohort study

33. SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

34. Risk for Hepatitis E Virus Transmission by Solvent/Detergent-Treated Plasma

35. Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?

36. Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017

37. Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

38. Seroprevalence Study of Anti-HEV IgG among Different Adult Populations in Corsica, France, 2019

39. Chikungunya, a risk factor for Guillain-Barré syndrome

40. Assessing Zika Virus Transmission within Households during an Outbreak in Martinique, 2015-2016

41. Persisting higher prevalence of hepatitis A virus RNA in blood donors, France, 2018

42. An Innovative Multiplexed And Flexible Molecular Approach For The Differential Detection Of Arboviruses

43. Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017

44. Zika virus epidemiology in Bolivia : A seroprevalence study in volunteer blood donors

45. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

46. Rapid identification of microorganisms from platelet concentrates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry after short-term incubation on liquid medium

47. Hepatitis E and blood donation safety in selected European countries: a shift to screening?

48. Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors

49. Epidemiology of Chikungunya Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational Study in Volunteer Blood Donors

50. An innovative multiplexed and flexible molecular approach for the differential diagnosis of arboviruses

Catalog

Books, media, physical & digital resources